Johnson & Johnson (NYSE: JNJ) announced today the U.S. Food and Drug Administration (FDA) approval of a supplemental New Drug Application (sNDA) for SPRAVATO® (esketamine) CIII nasal spray, making ...
Preeclampsia in pregnancy is a condition characterized by high blood pressure and high protein in the urine during pregnancy or right after delivery. It usually develops after 20 weeks of pregnancy.